Beclazone Easi-Breathe to be phased out

Teva has confirmed that they will cease supply of all strengths of Beclazone Easi-Breathe (beclometasone diproprionate) inhalers from 30 September 2009. The inhalers are being discontinued in line with the Montreal Protocol requirements to phase out manufacture of all CFC-containing beclometasone products by 2010.

Patients on Beclazone Easi-Breathe will need to be transferred to an alternative device and/or product that suits the patient.

The discontinuation does not affect Qvar Easi-Breathe or Salamol Easi-Breathe.

View Beclazone Easi-Breathe drug record

Further information: Teva

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

A woman wearing a white vest as a blue-gloved hand of a healthcare professional are seen injecting a vaccine.

'Nocebo' effect may cause two-thirds of COVID-19 vaccine reactions, study suggests

Two-thirds of adverse reactions reported with the COVID-19...

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...